Two new researches offer proof that earlier Dengue infection in pregnant ladies might result in elevated severity of Zika in infants, and that earlier Zika infection in female mice might increase severity of Dengue infection in their babies. The study, posted in the Cell Host & Microbe journal, supports that maternally-obtained antibodies for one virus can help infection by the other by a procedure exclusive to flaviviruses.
“We have witnessed Zika infections in humans lower in 2016 from their peak, but it is still a major concern and may re-emerge,” claims senior author Mehul Suthar, Emory University’s viral immunologist whose team researched human placental tissue to discover out how antibodies of Dengue assist transfer the Zika virus all over the placental obstruction. “The areas where Zika and Dengue are common overlap widely, so it is significant to understand how immune actions to one might influence weakness to the other.”
On a related note, experts in the U.K. plan to exploit the Zika virus trying to destroy brain tumor cells in tests that they say can bring about new means to battle against a violent kind of cancer. The study will aim on glioblastoma, the most ordinary type of brain cancer, which has a 5-year rate of survival with hardly 5%.
Zika results in harsh disability in offspring by destroying the growing stem cells in the brain; but in grownups, whose brains are completely developed, it often results in simply gentle symptoms similar to that of flu. In glioblastoma, the cells of cancer are much alike to those in the growing brain, signifying that the virus can be utilized to aim them while sparing usual brain tissue of adult. Scientists say that current treatments have to be offered at low measures to prevent injuring fit tissue. Experts led at Cambridge University by Harry Bulstrode will employ tumor cells present in the lab on mice to evaluate potential of the Zika virus.